PAR 7.02% 26.5¢ paradigm biopharmaceuticals limited..

PAR & Chrons Disease

  1. 4,244 Posts.
    lightbulb Created with Sketch. 6726
    Paradigmers, Tonight, welcome to another special report on our most magnificent company.

    As we wait (patiently, some more than others) for more news after a great week in terms of SP (Opened the week at $1.53 and closed at $1.75) what better time to present to you another wonderful stream of potential revenue for ourglorious PAR that may eventuate after some years?

    Tonight I tackle yet another inflammatory condition, namely Chrons and Colitis.Personally I have only heard of Chron's as a dear Uni friend had it many years ago. Honestly till now, I never researched much into it...but here are my basic findings.As per usual, these are my opinions and you should do your own research in terms of any forward looking statements or the disease itself and/or possible remedies for yourself/others.


    https://hotcopper.com.au/data/attachments/1637/1637895-4c7622f83dc54bf6224e0fb4150c8f74.jpg
    Chrons Disease

    WHAT IS IT?

    "Crohn’s Disease and ulcerative colitis are Iife long gastrointestinal disorders that commonly present themselves in children, adolescents and adulthood.Collectively known as Inflammatory Bowel Disease (IBD), the conditions are an emerging global disease". 1

    WHAT ARE THE CURRENT REMEDIES?

    Unfortunately, the nasty Corticosteroids rears its ugly head once more...see my post on comparable remedies and their nasty side effects:https://hotcopper.com.au/threads/the-competition-and-their-side-effects.4684627/?get_post=true

    "Corticosteroids such as prednisone and budesonide (Entocort EC) can help reduce inflammation in your body, but they don't work for everyone with Crohn's disease". 2

    HOW CAN PPS HELP?

    As most of us are aware by now, PAR's IPPS is an inflammtory solution. It has very little if any side effects and it could be used hereto relieve symptoms of Chrons and possibly Colitis.

    WHAT ARE THE NUMBERS?

    Australia has one of the highest prevalence in the world with some 80,000 affected. Its expected that this number will increase to some 100,000 by 2022.There are approximately 780,000 Americans that have Chron's. Paradigmers, again the numbers in this field are large!It will be some time before we can potentially see PAR investigating this area. We know officially that their focus is currently on OA, MPS and RRV.I'm not sure if they would have to necessarily conduct a future trial as I'm assuming the way to treat this would be with the same iPPS formula, meaning an extra revenuestream may not be that far away after we get the wonderful news someday that iPPS is commercialised and fit to use! Can you imagine what a day that will befor all of us?


    https://hotcopper.com.au/data/attachments/1637/1637896-0bf47cc51a2e1c7c9e1533b24d240cb3.jpg
    Potential Multiple Streams could one day flood our share accounts!


    PAST STREAMS

    Here at HC I've covered some amazing potential streams so far:

    COPD: https://hotcopper.com.au/threads/par-copd.4822883/?post_id=39191423
    Heart: https://hotcopper.com.au/threads/par-matters-of-the-heart.4731269/?post_id=38291009

    THE FUTURE

    My fellow Paradigmers, there are so many potential areas where PPS can assist, multiple streams look like they may one day eventuate for us.
    Very exciting times ahead for us. Please like always, DYOR and don't rely on anything I've said. Definitely Chrons is another area to investigate at some point in the near distance, I don't know about you, but I'm looking forward to a bright PARamount future!

    References:
    (1) https://www.crohnsandcolitis.com.au/about-crohns-colitis/
    (2) https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
-0.020(7.02%)
Mkt cap ! $92.69M
Open High Low Value Volume
29.0¢ 29.0¢ 26.0¢ $229.3K 833.1K

Buyers (Bids)

No. Vol. Price($)
9 89111 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 25136 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.